EP3069731 - ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 16.10.2020 Database last updated on 22.08.2024 | |
Former | Examination is in progress Status updated on 20.10.2017 | ||
Former | Request for examination was made Status updated on 24.03.2017 | Most recent event Tooltip | 16.10.2020 | New entry: Date of cancellation oral proceedings | 16.10.2020 | Withdrawal of application | published on 18.11.2020 [2020/47] | Applicant(s) | For all designated states Teva Pharmaceuticals International GmbH Schlüsselstrasse 12 8645 Jona / CH | [2017/30] |
Former [2016/38] | For all designated states Labrys Biologics Inc. 735 Galveston Drive Redwood City, CA 94063 / US | Inventor(s) | 01 /
ZELLER, Joerg 1002 Sunnyside Boulevard Ann Arbor, MI Michigan 48103 / US | 02 /
POULSEN, Kristian Todd 2080 Third Street, No. 7 San Francisco, CA California 94107 / US | 03 /
ABDICHE, Yasmina Noubia 183 Ada Avenue, Unit A Mountain View, CA California 94043 / US | 04 /
PONS, Jaume 1723 Hickory Avenue San Bruno, CA California 94066 / US | 05 /
ROSENTHAL, Arnon 150 Normandy Lane Woodside, CA California 94062 / US | 06 /
COLLIER, Sierra Jones 521 - 7th Avenue Menlo Park, CA California 94025 / US | [2016/38] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2016/38] | Application number, filing date | 16154411.9 | 02.11.2006 | [2016/38] | Priority number, date | US20050736623P | 14.11.2005 Original published format: US 736623 P | [2016/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3069731 | Date: | 21.09.2016 | Language: | EN | [2016/38] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.07.2016 | Classification | IPC: | A61K39/395, A61P5/24 | [2016/38] | CPC: |
A61K31/4045 (EP,US);
C07K16/18 (NO,US);
A61K39/395 (KR,NO);
A61K39/3955 (EP,US);
A61P25/00 (EP);
A61P25/06 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/24 (EP);
A61P9/00 (EP);
C07K16/00 (KR);
C07K16/26 (EP,US);
A61K2039/505 (EP,US);
C07K2317/21 (US);
C07K2317/24 (US);
C07K2317/33 (EP,US);
C07K2317/34 (EP,US);
C07K2317/52 (US);
C07K2317/55 (EP,US);
C07K2317/56 (US);
C07K2317/565 (EP,US);
C07K2317/567 (US);
C07K2317/70 (EP,US);
C07K2317/71 (US);
C07K2317/76 (EP,US);
C07K2317/92 (EP,US);
C07K2317/94 (US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2017/17] |
Former [2016/38] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 20.03.2017 | BA | 20.03.2017 | HR | 20.03.2017 | MK | 20.03.2017 | RS | 20.03.2017 | Title | German: | ANTAGONISTISCHE ANTIKÖRPER GEGEN CALCITONINGEN-ASSOZIIERTES PEPTID UND VERFAHREN DAMIT | [2016/38] | English: | ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME | [2016/38] | French: | ANTAGONISTES D'ANTICORPS DIRIGÉS CONTRE UN PEPTIDE ASSOCIÉ AU GÈNE DE LA CALCITONINE ET PROCÉDÉS LES UTILISANT | [2016/38] | Examination procedure | 05.02.2016 | Date on which the examining division has become responsible | 20.03.2017 | Examination requested [2017/17] | 03.05.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 13.07.2017 | Amendment by applicant (claims and/or description) | 20.10.2017 | Despatch of a communication from the examining division (Time limit: M04) | 08.01.2018 | Observations by third parties | 28.02.2018 | Reply to a communication from the examining division | 07.03.2018 | Observations by third parties | 22.03.2018 | Despatch of a communication from the examining division (Time limit: M04) | 01.08.2018 | Reply to a communication from the examining division | 27.11.2018 | Despatch of a communication from the examining division (Time limit: M06) | 28.05.2019 | Reply to a communication from the examining division | 14.10.2020 | Application withdrawn by applicant [2020/47] | 14.10.2020 | Cancellation of oral proceeding that was planned for 11.11.2020 | 11.11.2020 | Date of oral proceedings (cancelled) | Parent application(s) Tooltip | EP06809207.1 / EP1957106 | EP11166787.9 / EP2380592 | Divisional application(s) | EP20200867.8 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 13.07.2017 | Request for further processing filed | 13.07.2017 | Full payment received (date of receipt of payment) Request granted | 25.07.2017 | Decision despatched | Fees paid | Renewal fee | 05.02.2016 | Renewal fee patent year 03 | 05.02.2016 | Renewal fee patent year 04 | 05.02.2016 | Renewal fee patent year 05 | 05.02.2016 | Renewal fee patent year 06 | 05.02.2016 | Renewal fee patent year 07 | 05.02.2016 | Renewal fee patent year 08 | 05.02.2016 | Renewal fee patent year 09 | 05.02.2016 | Renewal fee patent year 10 | 23.11.2016 | Renewal fee patent year 11 | 24.11.2017 | Renewal fee patent year 12 | 22.11.2018 | Renewal fee patent year 13 | 26.11.2019 | Renewal fee patent year 14 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2005234054 (MUELLER STEPHAN G [DE], et al) [Y] 1-18 * paragraphs [0065] , [0066] *; | [Y] - TAN K K ET AL, "Calcitonin gene-related peptide as an endogenous vasodilator: immunoblockade studies in vivo with an anti-calcitonin gene-related peptide monoclonal antibody and its Fab' fragment.", CLINICAL SCIENCE (LONDON, ENGLAND : 1979) DEC 1995, (199512), vol. 89, no. 6, ISSN 0143-5221, pages 565 - 573, XP009082539 [Y] 1-18 * the whole document * DOI: http://dx.doi.org/10.1042/cs0890565 | [Y] - FROBERT Y ET AL, "A sensitive sandwich enzyme immunoassay for calcitonin gene-related peptide (CGRP): characterization and application.", PEPTIDES 1999, (1999), vol. 20, no. 2, ISSN 0196-9781, pages 275 - 284, XP002430636 [Y] 1-18 * the whole document * DOI: http://dx.doi.org/10.1016/S0196-9781(98)00172-7 | [Y] - HONG KI WHAN ET AL, "Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles", AMERICAN JOURNAL OF PHYSIOLOGY, AMERICAN PHYSIOLOGICAL SOCIETY, US, (19960101), vol. 270, no. 1, ISSN 0002-9513, pages H317 - H323, XP009190587 [Y] 1-18 * page H320, column r, line 1 - page H321, column r, paragraph 3 * | [Y] - BUCKLEY T L ET AL, "THE PARTIAL INHINITION OF INFLAMMATORY RESPONSES INDUCED BY CAPSAICIN USING THE FAB FRAGMENT OF A SELECTIVE CALCITONIN GENE-RELATED PEPTIDE ANTISERUM IN RABBIT SKIN", NEUROSCIENCE, NEW YORK, NY, US, (1992), vol. 48, no. 4, ISSN 0306-4522, pages 963 - 968, XP000563679 [Y] 1-18 * the whole document * DOI: http://dx.doi.org/10.1016/0306-4522(92)90284-9 | [Y] - BALINT R F ET AL, "ANTIBODY ENGINEERING BY PARSIMONIOUS MUTAGENESIS", GENE, ELSEVIER, AMSTERDAM, NL, (19931227), vol. 137, no. 1, ISSN 0378-1119, pages 109 - 118, XP002031537 [Y] 1-18 * page 110, column R * DOI: http://dx.doi.org/10.1016/0378-1119(93)90258-5 | [Y] - ASAHINA A ET AL, "Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: Relevance to functional effects", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1995), vol. 92, no. 18, ISSN 0027-8424, pages 8323 - 8327, XP002759007 [Y] 1-18 * abstract * | [A] - LITTLE M ET AL, "Of mice and men: hybridoma and recombinant antibodies", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (20000801), vol. 21, no. 8, ISSN 0167-5699, pages 364 - 370, XP004215163 [A] 1-18 * abstract * DOI: http://dx.doi.org/10.1016/S0167-5699(00)01668-6 | [A] - HOLT L J ET AL, "Domain antibodies: proteins for therapy", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (200311), vol. 21, no. 11, ISSN 0167-7799, pages 484 - 490, XP004467495 [A] 1-18 * abstract * DOI: http://dx.doi.org/10.1016/j.tibtech.2003.08.007 | [A] - DAVIES J ET AL, "Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding", IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, (199609), vol. 2, no. 3, ISSN 1380-2933, pages 169 - 179, XP004070292 [A] 1-18 * abstract * DOI: http://dx.doi.org/10.1016/S1380-2933(96)00045-0 | by applicant | US3773919 | EP0003089 | US4485045 | US4544545 | US4676980 | US4683195 | US4683202 | WO8704462 | US4754065 | GB2200651 | US4777127 | US4800159 | US4816567 | EP0345242 | WO9007936 | WO9011092 | WO9100360 | WO9102805 | US5013556 | US5047335 | WO9114445 | WO9220373 | EP0519596 | EP0524968 | WO9303769 | WO9306213 | WO9311230 | WO9311218 | US5219740 | WO9319191 | WO9325698 | WO9325234 | US5278299 | WO9404690 | WO9412649 | WO9413622 | WO9423697 | WO9428938 | WO9500655 | WO9507994 | WO9511984 | WO9513796 | US5422120 | WO9530763 | US5500362 | US5510261 | WO9617072 | US5530101 | US5545807 | US5545806 | US5565332 | US5569825 | US5580717 | US5580859 | US5585089 | US5625126 | US5633425 | US5661016 | WO9742338 | US5693761 | US5693762 | US5733743 | US5750373 | GB9809951D | US5807715 | US5814482 | US5821337 | US5866692 | US5981568 | WO9958572 | US5997867 | US6054297 | WO0053211 | US6180370 | US6180377 | US6210671 | WO0127160 | US6265150 | US6331415 | US6350861 | US6376471 | US6413942 | US6436908 | WO2004058184 | - WYON ET AL., SCAND. J. UROL. NEPHROL., (2001), vol. 35, pages 92 - 96 | - WYON ET AL., MENOPAUSE, (2000), vol. 7, no. 1, pages 25 - 30 | - FREEDMAN AM, J. HUMAN BIOL., (2001), vol. 13, pages 453 - 464 | - KATOVICH ET AL., PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY & MEDICINE, (1990), vol. 193, no. 2, pages 129 - 35 | - BERENDSEN ET AL., EUROPEAN JOURNAL OF PHARMACOLOGY, (2001), vol. 419, no. 1, pages 47 - 54 | - DURHAM, N., ENGL. J. MED., (2004), vol. 350, pages 1073 - 1075 | - GOADSBY ET AL., ANN. NEUROL., (1990), vol. 28, pages 183 - 7 | - LASSEN ET AL., CEPHALALGIA, (2002), vol. 22, pages 54 - 61 | - BRAIN, S. ET AL., TRENDS IN PHARMACOLOGICAL SCIENCES, (2002), vol. 23, pages 51 - 53 | - GOADSBY ET AL., BRAIN, (2002), vol. 125, pages 1392 - 401 | - ARULMANI ET AL., CEPHALALGIA, (2005), vol. 25, pages 1082 - 1090 | - GIFFIN ET AL., CEPHALALGIA, (2003), vol. 23, pages 287 - 292 | - ARULMANI ET AL., EUR. J. PHARMACOL., (2004), vol. 500, pages 315 - 330 | - GOADSBY ET AL., NEW ENGL. J. MED., (2002), vol. 346, no. 4, pages 257 - 275 | - GOADSBY, P.J. ET AL., NEW ENGL. J. MED., (2002), vol. 346, no. 4, pages 257 - 275 | - EUR. J. IMMUNOL., (1999), vol. 29, pages 2613 - 2624 | - Methods in Molecular Biology, HUMANA PRESS | - Methods in Enzymology, ACADEMIC PRESS, INC. | - Handbook of Experimental Immunology | - KOHLER; MILSTEIN, NATURE, (1975), vol. 256, page 495 | - MCCAFFERTY ET AL., NATURE, (1990), vol. 348, pages 552 - 554 | - VAUGHAN ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 309 - 314 | - SHEETS ET AL., PNAS, (USA, (1998), vol. 95, pages 6157 - 6162 | - HOOGENBOOM; WINTER, J. MOL. BIOL., (1991), vol. 227, page 381 | - MARKS ET AL., J. MOL. BIOL., (1991), vol. 222, page 581 | - COLE ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, (1985), page 77 | - BOERNER ET AL., J. IMMUNOL., (1991), vol. 147, no. 1, pages 86 - 95 | - AL-LAZIKANI ET AL., J. MOLEC. BIOL., (1997), vol. 273, pages 927 - 948 | - RAVETCH; KINET, ANN. REV. IMMUNOL., (1991), vol. 9, pages 457 - 92 | - CAPEL ET AL., IMMUNOMETHODS, (1994), vol. 4, pages 25 - 34 | - DE HAAS ET AL., J. LAB. CLIN. MED., (1995), vol. 126, pages 330 - 41 | - GUYER ET AL., J. IMMUNOL., (1976), vol. 117, page 587 | - KIM ET AL., J. IMMUNOL., (1994), vol. 24, page 249 | - GAZZANO-SANTORO ET AL., J. IMMUNOL. METHODS, (1996), vol. 202, page 163 | - CLYNES ET AL., PNAS (USA, (1998), vol. 95, pages 652 - 656 | - EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, page 3688 | - HWANG ET AL., PROC. NATL ACAD. SCI. USA, (1980), vol. 77, page 4030 | - GOADSBY ET AL., N. ENGL. J. MED., (2002), vol. 346, pages 257 - 270 | - TAN ET AL., CLIN. SCI. (LOND)., (1995), vol. 89, pages 565 - 73 | - PLOURDE ET AL., PEPTIDES, (1993), vol. 14, pages 1225 - 1229 | - EUR. J. LMMUNOL., (1999), vol. 29, pages 2613 - 2624 | - KARLSSON, R. ROOS, H. FAGERSTAM, L. PETERSSON, B., METHODS ENZYMOLOGY, (1994), vol. 6, pages 99 - 110 | - KOHLER, B.; MILSTEIN, C., NATURE, (1975), vol. 256, pages 495 - 497 | - BUCK, D. W. ET AL., IN VITRO, (1982), vol. 18, pages 377 - 381 | - WINTER ET AL., NATURE, (1991), vol. 349, pages 293 - 299 | - LOBUGLIO ET AL., PROC. NAT. ACAD. SCI. USA, (1989), vol. 86, pages 4220 - 4224 | - SHAW ET AL., J LMMUNOL., (1987), vol. 138, pages 4534 - 4538 | - BROWN ET AL., CANCER RES., (1987), vol. 47, pages 3577 - 3583 | - RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 327 | - VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536 | - JONES ET AL., NATURE, (1986), vol. 321, pages 522 - 525 | - DAUGHERTY ET AL., NUCL. ACIDS RES., (1991), vol. 19, pages 2471 - 2476 | - WINTER ET AL., ANNU. REV. IMMUNOL., (1994), vol. 12, pages 433 - 455 | - MCCAFFERTY ET AL., NATURE, (1990), vol. 348, pages 552 - 553 | - JOHNSON, KEVIN S.; CHISWELL, DAVID J., CURRENT OPINION IN STRUCTURAL BIOLOGY, (1993), vol. 3, pages 564 - 571 | - CLACKSON ET AL., NATURE, (1991), vol. 352, pages 624 - 628 | - MARK ET AL., J. MOL. BIOL., (1991), vol. 222, pages 581 - 597 | - GRIFFITH ET AL., EMBO J., (1993), vol. 12, pages 725 - 734 | - MARKS ET AL., BIO/TECHNOL., (1992), vol. 10, pages 779 - 783 | - WATERHOUSE ET AL., NUCL. ACIDS RES., (1993), vol. 21, pages 2265 - 2266 | - PEETERS ET AL., VACCINE, (2001), vol. 19, page 2756 | - LONBERG, N.; D. HUSZAR, LNT.REV.LMMUNOL, (1995), vol. 13, page 65 | - POLLOCK ET AL., J IMMUNOL METHODS, (1999), vol. 231, page 147 | - MORRISON ET AL., PROC. NAT. ACAD. SCI., (1984), vol. 81, page 6851 | - ESCOTT ET AL., BR. J. PHARMACOL., (1993), vol. 110, pages 772 - 776 | - REUTER ET AL., FUNCTIONAL NEUROLOGY, (2000), vol. 15, no. 3 | - FINDEIS ET AL., TRENDS BIOTECHNOL, (1993), vol. 11, page 202 | - WU ET AL., J. BIOL. CHEM., (1988), vol. 263, page 621 | - WU, J. BIOL. CHEM., (1994), vol. 269, page 542 | - ZENKE ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, page 3655 | - WU ET AL., J. BIOL. CHEM., (1991), vol. 266, page 338 | - JOLLY, CANCER GENE THERAPY, (1994), vol. 1, page 51 | - KIMURA, HUMAN GENE THERAPY, (1994), vol. 5, page 845 | - CONNELLY, HUMAN GENE THERAPY, (1995), vol. 1, page 185 | - KAPLITT, NATURE GENETICS, (1994), vol. 6, page 148 | - CURIEL, HUM. GENE THER., (1992), vol. 3, page 147 | - WU, J. BIOL. CHEM., (1989), vol. 264, page 16985 | - PHILIP, MOL. CELL BIOL., (1994), vol. 14, page 2411 | - WOFFENDIN, PROC. NATL. ACAD. SCI., (1994), vol. 91, page 1581 | - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426 | - HOLLIGER, P. ET AL., PROC. NATL. ACAD SCI. USA, (1993), vol. 90, pages 6444 - 6448 | - POLJAK, R. J. ET AL., STRUCTURE, (1994), vol. 2, pages 1121 - 1123 | - SURESH ET AL., METHODS IN ENZYMOLOGY, (1986), vol. 121, page 210 | - MILLSTEIN; CUELLO, NATURE, (1983), vol. 305, pages 537 - 539 | - JEFFERIS; LUND, CHEM. IMMUNOL., (1997), vol. 65, pages 111 - 128 | - WRIGHT; MORRISON, TIBTECH, (1997), vol. 15, pages 26 - 32 | - BOYD ET AL., MOL. LMMUNOL., (1996), vol. 32, pages 1311 - 1318 | - WITTWE; HOWARD, BIOCHEM., (1990), vol. 29, pages 4175 - 4180 | - WYSS; WAGNER, CURRENT OPIN. BIOTECH., (1996), vol. 7, pages 409 - 416 | - UMANA ET AL., MATURE BIOTECH., (1999), vol. 17, pages 176 - 180 | - HSE ET AL., J. BIOL. CHEM., (1997), vol. 272, pages 9062 - 9070 | - MORGAN ET AL., IMMUNOLOGY, (1995), vol. 86, pages 319 - 324 | - LUND ET AL., J. IMMUNOLOGY, (1996), vol. 157, pages 4963 - 4969 | - LDUSOGIE ET AL., J. IMMUNOLOGY, (2000), vol. 164, pages 4178 - 4184 | - TAO ET AL., J. IMMUNOLOGY, (1989), vol. 143, pages 2595 - 2601 | - JEFFERIS ET AL., IMMUNOLOGICAL REVIEWS, (1998), vol. 163, pages 59 - 76 | - EUR. J. IMMUNOL, (1999), vol. 29, pages 2613 - 2624 | - H. SEE, TAO ET AL., J. IMMUNOLOGY, (1989), vol. 143, pages 2595 - 2601 | - MARKS ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 779 - 783 | - BARBAS ET AL., PROC NAT. ACAD. SCI, USA, (1994), vol. 91, pages 3809 - 3813 | - SCHIER ET AL., GENE, (1995), vol. 169, pages 147 - 155 | - YELTON ET AL., J. IMMUNOL., (1995), vol. 155, pages 1994 - 2004 | - JACKSON ET AL., J. IMMUNOL., (1995), vol. 154, no. 7, pages 3310 - 9 | - HAWKINS ET AL., J. MOL. BIOL., (1992), vol. 226, pages 889 - 896 | - BALINT ET AL., GENE, (1993), vol. 137, no. L, pages 109 - 18 | - "A model of evolutionary change in proteins - Matrices for detecting distant relationships", DAYHOFF, M.O., Atlas of Protein Sequence and Structure, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, (1978), vol. 5, pages 345 - 358 | - "Unified Approach to Alignment and Phylogenes", HEIN J., Methods in Enzymology, ACADEMIC PRESS, INC., (1990), vol. 183, pages 626 - 645 | - HIGGINS, D.G.; SHARP, P.M., CABIOS, (1989), vol. 5, pages 151 - 153 | - MYERS, E.W.; MULLER W., CABIOS, (1988), vol. 4, pages 11 - 17 | - ROBINSON, E.D., COMB. THEOR, (1971), vol. 11, page 105 | - SANTOU, N.; NES, M., MOL. BIOL. EVOL., (1987), vol. 4, pages 406 - 425 | - WILBUR, W.J.; LIPMAN, D.J., PROC. NATL. ACAD. SCI. USA, (1983), vol. 80, pages 726 - 730 | - GEERLIGS HJ ET AL., J. IMMUNOL. METHODS, (1989), vol. 124, pages 95 - 102 | - KENNEY JS ET AL., J. IMMUNOL. METHODS, (1989), vol. 121, pages 157 - 166 | - WICHER K ET AL., INT. ARCH. ALLERGY APPL. IMMUNOL., (1989), vol. 89, pages 128 - 135 | - KARLSSON, R. ROOS; H. FAGERSTAM; L. PETERSSON, B, METHODS ENZYMOLOGY, (1994), vol. 6, pages 99 - 110 | - ZIMMERMANN ET AL., PEPTIDES, (1995), vol. 16, pages 421 - 4 | - MALLEE ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 14294 - 8 | - TAN ET AL., CLIN. SCI., (1995), vol. 89, pages 656 - 73 | - WILLIAMSON ET AL., CEPHALALGIA, (1997), vol. 17, no. 4, pages 518 - 24 | - SIPE ET AL., BRAIN RES., (2004), vol. 1028, no. 2, pages 191 - 202 | - MERCHENTHALER ET AL., MATURITAS, (1998), vol. 30, pages 307 - 316 | - KATOVICH ET AL., BRAIN RES., (1989), vol. 494, pages 85 - 94 | - SIMPKINS ET AL., LIFE SCIENCES, (1983), vol. 32, pages 1957 - 1966 | WO2041GB99014 | other | US2002164707 | US2004110170 | WO2007054809 | - Transcript of the Teva Q3 Earning Call, (20171107), URL: https://seekingalpha.com/article/4119613-teva-pharmaceutical-industries-teva-q3-2017-results-earnings-call-transcript?part=single#question-answer-session | - L. EDVINSSON, "New therapeutic target in primary headaches - blocking the CGRP receptor", Expert Opinion on Therapeutic Targets, (20030000), vol. 7, no. 3, pages 377 - 383 |